Increased platelet activation in advanced liver disease (Panasiuk et al. 2001) might also contribute to elevated CCN-2, since platelets contain large amounts of full length CCN-2 that is released upon activation (Cicha et al. 2004; Miyazaki et al. 2010). The gene discussed is CCN2; the disease is liver disorder.